VTORIChNAYa PROFILAKTIKA IShEMIChESKOGO INSUL'TA: VSEM LI PATsIENTAM POKAZANA GIPOLIPIDEMIChESKAYa TERAPIYa?
Ya B Skiba , S N Yanishevskiy , A F Sukhoterin , I M Buchin , V D Puchek
Russian Military Medical Academy Reports ›› 2019, Vol. 38 ›› Issue (3 (Прил)) : 134 -136.
VTORIChNAYa PROFILAKTIKA IShEMIChESKOGO INSUL'TA: VSEM LI PATsIENTAM POKAZANA GIPOLIPIDEMIChESKAYa TERAPIYa?
| [1] |
Аверков О.В., Барбараш О.Л., Бойцов С.А., Васильева Е.Ю., Драпкина О.М., Галявич А.С., Гиляров М.Ю., Зайратьянц О.В., Кактурский Л.В., Карпов Ю.А., Мишнев О.Д., Никулина Н.Н., Орехов О.О., Самородская И.В., Соболева Г.Н., Черкасов С.Н., Шахнович Р.М., Шилова А.С., Шляхто Е.В., Шпектор А.В., Явелов И.С., Якушин С.С. Дифференцированный подход в диагностике, формулировке диагноза, ведении больных и статистическом учете инфаркта миокарда 2 типа (согласованная позиция) // РКЖ. - 2019. - №6. - 7-21. |
| [2] |
Вознюк И.А., Янишевский С.Н. и др. Ишемический инсульт: клинические рекомендации по первичной и вторичной профилактике/ СПб.: Стикс, 2018. - 32 с. |
| [3] |
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias // European Heart Journal. - 2016. - № 37. - 2999-3058. |
| [4] |
Amarenco P, Benavente O, Goldstein LB, et al. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes // Stroke. - 2009. - DOI: 10.1161/strokeaha.108.534107. |
| [5] |
Amarenco P., Bogousslavsky J., Callahan A. High-dose atorvastatin after stroke or transient ischemic attack // N. Engl. J. Med. - 2006. - № 355. -549-559. |
| [6] |
Amarenco P., Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention // Lancet Neurol. - 2009. - № 8. - 453-463. |
| [7] |
Grundy S.M., Stone N.J., Bailey A.L., Beam C., Birtcher K.K., Blumenthal R.S., Braun L.T., de Ferranti S. 2018 AHA/ACC/ AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines // Circulation. - 2018: DOI: 10.1161/CIR.0000000000000625. |
| [8] |
Heart Protection Collaborative Study Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions // Lancet. - 2004. - № 363. - 757-767. |
| [9] |
Kernan W.N., Ovbiagele B., Kittner S.J. on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association /American Stroke Association // Stroke. - 2014. - № 45. - 2160-2236. |
| [10] |
Sillesen H., Amarenco P., Hennerici M.G. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial // Stroke. - 2008. - № 39. - 3297-3302. |
| [11] |
Wu Y.L., Saver J.L., Chen P.C. Effect of statin use on clinical outcomes in ischemic stroke patients with atrial fibrillation // Medicine (Baltimore). -2017. - № 5 (96). - doi:10.1097/MD.0000000000005918. |
Skiba Y.B., Yanishevskiy S.N., Sukhoterin A.F., Buchin I.M., Puchek V.D.
/
| 〈 |
|
〉 |
PDF
